| 000 | 01095 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250514011404.0 | ||
| 264 | 0 | _c20011025 | |
| 008 | 200110s 0 0 eng d | ||
| 022 | _a0011-5029 | ||
| 024 | 7 |
_a10.1067/mda.2001.118859 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aToth, P P | |
| 245 | 0 | 0 |
_aHigh-density lipoprotein: epidemiology, metabolism, and antiatherogenic effects. _h[electronic resource] |
| 260 |
_bDisease-a-month : DM _cAug 2001 |
||
| 300 |
_a369-416 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aApolipoprotein A-I _xmetabolism |
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCoronary Disease _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aLipoproteins, HDL _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRisk Factors |
| 773 | 0 |
_tDisease-a-month : DM _gvol. 47 _gno. 8 _gp. 369-416 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1067/mda.2001.118859 _zAvailable from publisher's website |
| 999 |
_c11493306 _d11493306 |
||